What bacteria are commonly associated with rhinosinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The bacteria most commonly associated with rhinosinusitis include Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus. In acute bacterial rhinosinusitis, Streptococcus pneumoniae accounts for approximately 30-35% of cases, followed by Haemophilus influenzae (20-25%) and Moraxella catarrhalis (10-15%) 1. Staphylococcus aureus is more frequently isolated in chronic rhinosinusitis cases, along with anaerobic bacteria such as Peptostreptococcus, Bacteroides, and Fusobacterium species. Pseudomonas aeruginosa and other gram-negative bacteria may be found in patients with underlying conditions like cystic fibrosis or immunodeficiency. The microbiology differs somewhat between acute and chronic cases, with viral pathogens often preceding bacterial infection in acute cases. Understanding the bacterial profile is important for appropriate antibiotic selection, with amoxicillin or amoxicillin-clavulanate typically used as first-line treatment for uncomplicated acute bacterial rhinosinusitis, while chronic cases may require culture-directed therapy and longer treatment courses 1. Some key points to consider when managing rhinosinusitis include:

  • The use of symptomatic treatment and reassurance as the preferred initial treatment strategy for patients with mild symptoms 1
  • The consideration of factors that predispose patients to antibiotic-resistant organisms when selecting antibiotics 1
  • The importance of patient education about the chosen treatment strategy and worsening signs and symptoms that should prompt them to contact a physician 1

From the FDA Drug Label

Azithromycin Tablets, USP are indicated for the treatment of patients with mild to moderate infections ... Acute bacterial sinusitis due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae. Amoxicillin and clavulanate potassium tablets USP is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: ... 1.3 Sinusitis – caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.

The bacteria commonly associated with rhinosinusitis are:

  • Haemophilus influenzae
  • Moraxella catarrhalis
  • Streptococcus pneumoniae 2 3

From the Research

Bacteria Associated with Rhinosinusitis

The bacteria commonly associated with rhinosinusitis include:

  • Streptococcus pneumoniae 4, 5, 6, 7, 8
  • Haemophilus influenzae 4, 5, 6, 7, 8
  • Moraxella catarrhalis 4, 5, 6, 8
  • Streptococcus pyogenes 5
  • Staphylococcus aureus 5
  • Anaerobic organisms (Prevotella and Porphyromonas, Fusobacterium, and Peptostreptococcus spp.) 5
  • Pseudomonas aeruginosa 5

Specific Bacteria in Different Types of Rhinosinusitis

  • Acute bacterial rhinosinusitis: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis 4, 6, 7, 8
  • Chronic rhinosinusitis: Staphylococcus aureus, anaerobic organisms (Prevotella and Porphyromonas, Fusobacterium, and Peptostreptococcus spp.) 5
  • Nosocomial sinusitis: Pseudomonas aeruginosa and other aerobic and facultative Gram-negative rods 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microbiology of chronic rhinosinusitis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016

Research

The efficacy of cefdinir in acute bacterial rhinosinusitis.

Expert opinion on pharmacotherapy, 2006

Research

Management of acute bacterial rhinosinusitis.

Current opinion in pediatrics, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.